{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:35:30Z","timestamp":1790127330918,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s13181-018-0653-9","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T13:21:00Z","timestamp":1518096060000},"page":"120-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8714-9956","authenticated-orcid":false,"given":"Mark","family":"Yarema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco L. A.","family":"Sivilotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Nettel-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlemaigne","family":"Victorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gosselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Purssell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Spyker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Rumack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"issue":"6","key":"653_CR1","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S0196-0644(98)70229-X","volume":"31","author":"B Bailey","year":"1998","unstructured":"Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med. 1998 Jun;31(6):710\u20135. https:\/\/doi.org\/10.1016\/S0196-0644(98)70229-X .","journal-title":"Ann Emerg Med"},{"issue":"6","key":"653_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0196-0644(03)00508-0","volume":"42","author":"LW Kao","year":"2003","unstructured":"Kao LW, Kirk MA, Furbee RB, Mehta NH, Skinner JR, Brizendine EJ. What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning? Ann Emerg Med. 2003 Dec;42(6):741\u201350. https:\/\/doi.org\/10.1016\/S0196-0644(03)00508-0 .","journal-title":"Ann Emerg Med"},{"issue":"2","key":"653_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/15563650802665587","volume":"47","author":"E Sandilands","year":"2009","unstructured":"Sandilands E, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol. 2009;47(2):81\u20138. https:\/\/doi.org\/10.1080\/15563650802665587 .","journal-title":"Clin Toxicol"},{"key":"653_CR4","first-page":"10","volume":"12","author":"RM Lynch","year":"2004","unstructured":"Lynch RM, Robertson R. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. AccidEmergNurs. 2004 Jan;12:10\u20135.","journal-title":"AccidEmergNurs"},{"issue":"2","key":"653_CR5","first-page":"108","volume":"11","author":"F Gheshlaghi","year":"2006","unstructured":"Gheshlaghi F, Eizadi-Mood N. Atopic diseases: risk factor in developing adverse reaction to intravenous N-acetylcysteine. J Res Med Sci. 2006;11(2):108\u201310.","journal-title":"J Res Med Sci"},{"key":"653_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1365-2125.2001.01305.x","volume":"51","author":"LE Schmidt","year":"2001","unstructured":"Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol. 2001 Jan;51:87\u201391.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"653_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/emj.19.6.594","volume":"19","author":"AV Appelboam","year":"2002","unstructured":"Appelboam AV, Dargan PI, Knighton J. Fatal anaphylactoid reaction to N-acetylcysteine: caution in patients with asthma. Emerg Med J. 2002;19(6):594\u20135. https:\/\/doi.org\/10.1136\/emj.19.6.594 .","journal-title":"Emerg Med J"},{"issue":"6","key":"653_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/15563650701864760","volume":"46","author":"WS Waring","year":"2008","unstructured":"Waring WS, Stephen AF, Robinson OD, M a D, Pettie JM. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol. 2008;46(6):496\u2013500. https:\/\/doi.org\/10.1080\/15563650701864760 .","journal-title":"Clin Toxicol"},{"key":"653_CR9","first-page":"697","volume":"46","author":"N Pakravan","year":"2008","unstructured":"Pakravan N, Waring WS, Sharma S, Ludlam C, Megson I, Bateman DN. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. ClinToxicol. 2008;46:697\u2013702.","journal-title":"ClinToxicol"},{"issue":"6","key":"653_CR10","first-page":"467","volume":"51","author":"LE Schmidt","year":"2013","unstructured":"Schmidt LE. Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose. ClinToxicol. 2013 Jul;51(6):467\u201372.","journal-title":"ClinToxicol."},{"issue":"4","key":"653_CR11","first-page":"402","volume":"45","author":"F Kerr","year":"2005","unstructured":"Kerr F, Dawson A, Whyte IM, Buckley N, Murray L, Graudins A, et al. The Australasian clinical toxicology investigators collaboration randomized trial of different loading infusion rates of N-acetylcysteine. AnnEmergMed. 2005 Apr;45(4):402\u20138.","journal-title":"AnnEmergMed"},{"issue":"9918","key":"653_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(13)62062-0","volume":"383","author":"DN Bateman","year":"2014","unstructured":"Bateman DN, Dear JW, Thanacoody HK, Thomas SH, Eddleston M, Sandilands EA, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. Lancet. 2014 Feb 22;383(9918):697\u2013704. https:\/\/doi.org\/10.1016\/S0140-6736(13)62062-0 .","journal-title":"Lancet"},{"issue":"3","key":"653_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/bcp.12789","volume":"81","author":"AL Chiew","year":"2015","unstructured":"Chiew AL, Isbister GK, Duffull SB, Buckley NA. Evidence for the changing regimens of acetylcysteine. Br J Clin Pharmacol. 2015;81(3):471\u201381. https:\/\/doi.org\/10.1111\/bcp.12789 .","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"653_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.annemergmed.2009.05.010","volume":"54","author":"MC Yarema","year":"2009","unstructured":"Yarema MC, Johnson DW, Berlin RJ, Sivilotti ML, Nettel-Aguirre A, Brant RF, et al. Comparison of the 20 hour intravenous and the 72 hour oral acetylcysteine protocols in the treatment of acute acetaminophen poisoning. Ann Emerg Med. 2009;54(4):606\u201314. https:\/\/doi.org\/10.1016\/j.annemergmed.2009.05.010 .","journal-title":"Ann Emerg Med"},{"issue":"3","key":"653_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/bcp.12362","volume":"78","author":"DN Bateman","year":"2014","unstructured":"Bateman DN, Carroll R, Pettie J, Yamamoto T, Elamin M, Peart L, et al. Effect of the UK\u2019s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br J Clin Pharmacol. 2014;78(3):610\u20138. https:\/\/doi.org\/10.1111\/bcp.12362 .","journal-title":"Br J Clin Pharmacol"},{"issue":"6439","key":"653_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/bmj.289.6439.217","volume":"289","author":"TG Mant","year":"1984","unstructured":"Mant TG, Tempowski JH, Volans G, Talbot JC. Adverse reactions to acetylcysteine and effects of overdose. BMJ. 1984;289(6439):217\u20139. https:\/\/doi.org\/10.1136\/bmj.289.6439.217 .","journal-title":"BMJ"},{"issue":"6","key":"653_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5694\/j.1326-5377.1989.tb136496.x","volume":"150","author":"AH Dawson","year":"1989","unstructured":"Dawson AH, Henry DA, McEwen J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust. 1989;150(6):329\u201331.","journal-title":"Med J Aust"},{"key":"653_CR18","doi-asserted-by":"publisher","unstructured":"Brok J, Buckley N, Gluud C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev. 2006;(2):DOI: https:\/\/doi.org\/10.1002\/14651858.CD003328.pub2 .","DOI":"10.1002\/14651858.CD003328.pub2"},{"issue":"2","key":"653_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/15563650.2015.1115055","volume":"54","author":"A Wong","year":"2016","unstructured":"Wong A, Graudins A. Simplification of the standard three-bag intravenous acetylcysteine regimen for paracetamol poisoning results in a lower incidence of adverse drug reactions. Clin Toxicol. 2016;54(2):115\u20139. https:\/\/doi.org\/10.3109\/15563650.2015.1115055 .","journal-title":"Clin Toxicol"},{"issue":"5","key":"653_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15563650.2017.1408812","volume":"55","author":"R McNulty","year":"2017","unstructured":"McNulty R, Lim J, Chandru P, Gunja N. Fewer adverse effects with a modified 2-bag intravenous acetylcysteine protocol compared to the traditional 3-bag protocol in paracetamol overdose. Clin Toxicol. 2017;55(5):1\u20134.","journal-title":"Clin Toxicol"},{"issue":"2","key":"653_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/15563650.2015.1115057","volume":"54","author":"GK Isbister","year":"2016","unstructured":"Isbister GK, Downes MA, Mcnamara K, Berling I, Whyte IM, Page CB. A prospective observational study of a novel 2-phase infusion protocol for the administration of acetylcysteine in paracetamol poisoning. Clin Toxicol. 2016;54(2):120\u20136. https:\/\/doi.org\/10.3109\/15563650.2015.1115057 .","journal-title":"Clin Toxicol"},{"issue":"January","key":"653_CR22","first-page":"1","volume":"3650","author":"DN Bateman","year":"2015","unstructured":"Bateman DN, Dear JW, Thomas SH. New regimens for intravenous acetylcysteine, where are we now? Clin Toxicol. 2015;3650(January):1\u20134.","journal-title":"Clin Toxicol"},{"issue":"4","key":"653_CR23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jemermed.2006.08.004","volume":"31","author":"AF Pizon","year":"2006","unstructured":"Pizon AF, LoVecchio F. Adverse reaction from use of intravenous N-acetylcysteine. J Emerg Med. 2006 Nov;31(4):434\u20135. https:\/\/doi.org\/10.1016\/j.jemermed.2006.08.004 .","journal-title":"J Emerg Med"}],"updated-by":[{"DOI":"10.1007\/s13181-018-0657-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T00:00:00Z","timestamp":1520812800000}}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-018-0653-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-018-0653-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-018-0653-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T12:50:22Z","timestamp":1570711822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-018-0653-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["653"],"URL":"https:\/\/doi.org\/10.1007\/s13181-018-0653-9","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]},"assertion":[{"value":"24 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been corrected. Table 4 in PDF version of this article has been corrected since the original publication of the article because the first column of numbers (under the heading \u201cFemale\u201d) in the original PDF version was typeset poorly.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}